Kestrel Investment Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Hold
167,100
1.2% 32
2026
Q1
$1.57M Sell
167,100
-1,500
-0.9% -$13.4K 0.94% 36
2025
Q4
$1.36M Sell
168,600
-5,700
-3% -$62.3K 0.77% 38
2025
Q3
$2.48M Hold
174,300
1.4% 31
2025
Q2
$2.27M Sell
174,300
-8,200
-4% -$113K 1.36% 33
2025
Q1
$2.72M Hold
182,500
1.66% 29
2024
Q4
$3.31M Hold
182,500
1.83% 27
2024
Q3
$2.37M Buy
182,500
+13,100
+8% +$193K 1.37% 32
2024
Q2
$2.34M Hold
169,400
1.55% 30
2024
Q1
$3.17M Sell
169,400
-1,100
-0.6% -$22K 2.12% 21
2023
Q4
$3.86M Sell
170,500
-38,100
-18% -$826K 2.61% 18
2023
Q3
$5.17M Buy
+208,600
New +$5.25M 3.27% 14

Other funds holding CCRN

Kestrel Investment Management's CCRN Position: Q2 2026 in Review

Kestrel Investment Management held its Cross Country Healthcare (CCRN) position steady in Q2 2026 at 167,100 shares worth $2.21M. The position accounts for 1.2% of the portfolio, ranked #32.

Kestrel Investment Management first reported a position in CCRN in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.17M in Q3 2023. 49 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • Kestrel Investment Management held 167,100 shares of Cross Country Healthcare worth $2.21M as of Q2 2026.
  • Kestrel Investment Management left its Cross Country Healthcare share count unchanged in Q2 2026.
  • Cross Country Healthcare made up 1.2% of Kestrel Investment Management's portfolio in Q2 2026, its #32 holding.
  • Kestrel Investment Management first reported a position in Cross Country Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Kestrel Investment Management's Cross Country Healthcare position peaked at $5.17M in Q3 2023.
  • 49 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on Kestrel Investment Management's 13F filing for Q2 2026, filed 4 Aug 2026.